Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Great news on cancer, anyone awake out there?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(19)
•••
Comment by QM45on Nov 09, 2020 7:08pm
177 Views
Post# 31867670

RE:RE:RE:RE:RE:RE:RE:RE:RE:Great news on cancer, anyone awake out there?

RE:RE:RE:RE:RE:RE:RE:RE:RE:Great news on cancer, anyone awake out there? Respect Qwerty. Did not catch that, busy on the markets today and I did not see the T-Cell response when I glanced over it. My eye sight is not what it used to be and the font is ultra small. 

That indeed warrants attention although 75% response is nothing to sneeze at as it might be synergistic. Now what is leading what is not  as important as that they work together, but it certainly is important for MOA. Small sample size of three might be difficult to extrapolate from. 

I agree, Berstein should have some answers on the 12th. Hopefully they take Qs aside from analysts, but doubt it. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities